Skip to main content
. 2025 Nov 28;19:2049. doi: 10.3332/ecancer.2025.2049

Table 6. Univariate analysis- EFS and OS for whole cohort and Group III by time to local therapy.

Variable HR CI p value HR CI p value
For whole cohort (n = 51) For Group III (n = 35)
EFS
First modality of local therapy ≥12 weeks from start of chemotherapy 1.53 0.59–3.9 0.38 1.25 0.39, 3.94 0.7
Time to first modality of local therapy 1.05 1.00, 1.10 0.037 1.05 0.98, 1.1 0.13
OS
First modality of local therapy ≥12 weeks from start of chemotherapy 0.97 0.33–2.8 0.96 0.64 0.16, 2.58 0.53
Time to first modality of local therapy 1.01 0.96, 1.07 0.49 1 0.92, 1.07 0.98